Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-CAAP trial of corticosteroids plus IVIG and aspirin versus IVIG and aspirin in Kawasaki disease
2019-004433-17Phase 3Unknown
- Sponsor
- MRC Clinical Trials Unit at UCL
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Kawasaki disease (KD) comparing Corticosteroids + IVIG + aspirin with IVIG + aspirin (2 arms). Primary endpoint: Co-primary outcome measures. Status: unknown.
02
Drugs
prednisolonemethylprednisolonesubcuviaaspirin
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on 2019-004433-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004433-17.